Co-delivery of all-trans-retinoic acid enhances the anti-metastasis effect of albumin-bound paclitaxel nanoparticles

Chem Commun (Camb). 2016 Dec 20;53(1):212-215. doi: 10.1039/c6cc08146k.

Abstract

Co-delivery of all-trans-retinoic acid and paclitaxel using albumin-bound nanoparticles demonstrated a significantly improved anti-metastatic effect to breast cancer both in vitro and in vivo. Notably, the co-delivery nanoparticles exhibited more pronounced therapeutic effects than the combination of two free drugs or two HSA loaded single drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albumin-Bound Paclitaxel / chemistry*
  • Albumin-Bound Paclitaxel / pharmacology*
  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Drug Carriers / chemistry*
  • Humans
  • Mice
  • Models, Molecular
  • Nanoparticles / chemistry*
  • Neoplasm Metastasis
  • Protein Conformation
  • Tretinoin / chemistry*

Substances

  • Albumin-Bound Paclitaxel
  • Antineoplastic Agents
  • Drug Carriers
  • Tretinoin